Scientific studies & consumer anecdotes about healthier living by reversing NAD+ decline (for information purposes only)

Category: Ataxia

What Clinical Studies on Nicotinamide Riboside is Chromadex Most Excited About?

From yesterday’s Chromadex (sellers of Nicotinamide Riboside “NR” (FAQs) (Reviews)) earnings call:

New Clinical Trial Results Show Nicotinamide Riboside (NR) Impacting Patients with Ataxia Telangiectasia (AT)

In September, scientists reported promising results from a clinical study treating patients suffering from Ataxia Telangiectasia (AT) with NAD boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). For those unfamiliar, according to the Cleveland Clinic, “Ataxia is the term for a group of neurological diseases (diseases related to the nervous system) that affect movement and coordination”. Last week, the folks at NR seller Chromadex discussed the clinical findings during their latest earnings call:

Powered by WordPress & Theme by Anders Norén